Teresita Bellido Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

◆ ARA Academy Federal Grant PI High Impact

Musculoskeletal Health and Disease Research - UAMS Creativity Hub Leadership

University of Arkansas for Medical Sciences

faculty

TMBellido@uams.edu

74 h-index 311 pubs 22,699 cited

Research Areas

Links

ORCID Lab Website Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Teresita Bellido's research focuses on bone and musculoskeletal health, with a particular emphasis on the role of osteocytes in various disease states. Her work investigates the mechanisms underlying bone loss and repair, including the influence of signaling pathways and therapeutic interventions. Bellido has received federal funding for studies on glucocorticoid-induced atrophy in bone and muscle, as well as the contribution of osteocytes to the musculoskeletal effects of multiple myeloma. She also leads a research group and maintains an active lab website dedicated to her work in this area.

Her recent publications explore diverse topics such as the osteocyte as a signaling cell, the use of decellularized matrices for bone defect repair, and the reversal of diabetic bone signatures with anabolic therapies. Bellido has also investigated Notch signaling in the context of multiple myeloma and its impact on bone destruction, as well as the effects of bisphosphonates for osteoporosis. Her scholarship metrics include an h-index of 74, 311 total publications, and over 22,000 citations, indicating a significant body of published work. She has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Jesús Delgado‐Calle, Hayley M. Sabol, Amy Y. Sato, and Nisreen Akel.

Metrics

h-index: 74
Publications: 311
Citations: 22,699

Selected Publications

The development of a collagen-nanoscale hydroxyapatite three-dimensional (3D) in vitro culture system for reproducing osteocyte differentiation and tissue mineralization (2025) DOI
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma (2024) DOI
Generation of BT-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective <i>via</i> Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss (2024) DOI
Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease (2024) DOI
Sclerostin antibody corrects periodontal disease in type 2 diabetic mice (2024) DOI
Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male mice (2024) DOI
Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases (2023) DOI
OR29-04 Vitamin D Signaling Prevents Glucocorticoid-Induced Musculoskeletal Tissue Loss And Cardiac Dysfunction By Targeting The Atrogene Pathway (2023) DOI
THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies (2023) DOI
Loss of Nmp4 enhances bone gain from sclerostin antibody administration (2023) DOI
Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice (2023) DOI
Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice (2023) DOI
The <scp>LRP5</scp> high‐bone‐mass mutation causes alveolar bone accrual with minor craniofacial alteration (2023) DOI
Reversal of the diabetic bone signature with anabolic therapies in mice (2023) DOI
Data from Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity (2023) DOI

ARA Academy 2018 ARA Scholar

Dr. Bellido is an internationally recognized leader in bone research. She holds major grants from the NIH and Veterans Administration and has served as president of the American Society for Bone and Mineral Research (2020). Her research focuses on signal transduction in bone and muscle, with emphasis on osteocyte biology in health and disease and hormonal action mechanisms in the musculoskeletal system.

Policy Impact

Holds major NIH and VA grants; former president of the American Society for Bone and Mineral Research, bringing national leadership and federal funding to UAMS.